Navidea sells shares to raise funds for operations

01/30/2013 | Wall Street Journal, The

Navidea Biopharmaceuticals said it has sold 1.5 million shares to J.P. Morgan Chase & Co.'s asset management unit and an additional investor to raise money to support its operations while it waits for an FDA decision on its radiopharmaceutical agent Lymphoseek. Navidea expects a decision in April and is also pursuing European approval for the agent.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations